This study aims to investigate the effects of 24-hour acute sleep deprivation on plasma Alzheimer's disease biomarkers and multi-omics in individuals with different APOE genotypes, to elucidate the potential role of acute sleep deprivation in AD risk.
This is a randomized controlled trial designed to enroll 60 healthy volunteers. Stratified randomization will be used, with three strata defined by APOE genotype (APOE ε3/3, APOE ε4 carriers, and APOE ε2 carriers) in a 1:1:1 ratio. Within each stratum, participants will be randomly assigned in a 1:1 ratio to either the acute sleep-deprivation group or the non-acute sleep-deprivation group. The intervention will consist of 24 hours of acute sleep deprivation. The primary outcome measure is the change from baseline in plasma Aβ42 on the first day after randomization.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
60
Sleep deprivation for up to 24 hours with no naps or other sleep periods
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, China
RECRUITINGPlasma Aβ42 levels
Time frame: 1 day after randomization
Plasma Aβ40 levels
Time frame: 1 day after randomization
Plasma t-tau levels
Time frame: 1 day after randomization
Plasma p-tau181 levels
Time frame: 1 day after randomization
Plasma p-tau217 levels
Time frame: 1 day after randomization
Plasma NfL levels
Time frame: 1 day after randomization
Plasma GFAP levels
Time frame: 1 day after randomization
Plasma Aβ42/Aβ40 levels
Time frame: 1 day after randomization
Plasma t-tau/Aβ42 levels
Time frame: 1 day after randomization
Plasma p-tau181/Aβ42 levels
Time frame: 1 day after randomization
Plasma p-tau217/Aβ42 levels
Time frame: 1 day after randomization
Fatigue Scale-14
The Fatigue Scale-14 has a minimum score of 0 and a maximum score of 33; higher scores indicate greater fatigue severity.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 1 day after randomization
Positive and Negative Affect Schedule
The Positive and Negative Affect Schedule comprises two subscales: Positive Affect and Negative Affect. Each subscale ranges from 10 to 50, with higher scores indicating greater accumulation of the corresponding affect.
Time frame: 1 day after randomization
N-back tasks
N-back test, participants are required to identify target digits that match the stimuli presented N steps earlier on the screen
Time frame: 1 day after randomization